Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin PK and Dialyzability in ESRD
NCT05343078Phase 4Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in end stage renal disease (ESRD), sponsored by Universidade Estadual de Campinas. Started Apr 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05343078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05343078.